Pongamia pinnata: A Comprehensive Review of its Pharmacognostical Studies and Pharmacological Activities

 

Akash Jakkannavar, Sneha Patil*, Mrityunjaya Patil, Sunil Jalalpure, Akshay Patil

Department of Pharmacognosy, KLE College of Pharmacy, Belagavi, KLE academy of Higher Education and Research (KAHER), Nehru Nagar, Belagavi, Karnataka – 590010.

*Corresponding Author E-mail: snehabpatil@gmail.com

 

ABSTRACT:

Since ancient times, medicinal plants have been essential in the development of many modern drugs, and they continue to be a valuable source of new therapeutic agent. Pongamia. pinnata, commonly referred to as Karanj is a versatile tree belonging to the Fabaceae family which has been used in traditional medicine for centuries, offering a plethora of health benefits. This review aims to provide an exhaustive overview of the pharmacological and therapeutic potential of Pongamia pinnata, as well as its environmental applications. The plant contains several beneficial compounds, including fixed oils, carbohydrates, glycosides, flavonoids and alkaloids. P. pinnata is widely recognized for its anti-diabetic, anti-inflammatory, antifungal, antibacterial, antimalarial, antimicrobial, antiviral and antioxidant properties. Additionally, its seed oil can be utilized as a source of biodiesel. The pharmacognostic information will be promising tool for establishing standards for purity, quality and sample identification.  This comprehensive review provides a thorough understanding of Pongamia pinnata's multifaceted applications, emphasizing its importance in promoting human health and environmental sustainability. Our findings suggest that further research is necessary to fully explore its potential and optimize its uses.

 

KEYWORDS: Karanj, Pongamia pinnata, Phytochemicals, Pharmacological properties Analytical profile, Quality control.

 

 


INTRODUCTION: 

Herbal medicine has been important for thousands of years and continues to play a significant role in healthcare for several reasons1,2. In the global healthcare system, the use of ayurvedic drugs and herbal formulations which comprise herbs, raw materials, herbal preparations and finished products has become potential important.3,4 A single herb may contain hundreds or thousands of chemical components which combine to produce pharmacological effects through a complicated web of targets and pathways.5

 

 

Herbal treatments with a variety of phytoconstituents and properties have been used for centuries to treat a wide range of ailments.6,7 The natural occurrence, effectiveness, and low frequency of adverse effects of these drugs have all been linked to their inherent safety8,9. Pongamia pinnata is a significant species within the Fabaceae family10. It is known by a number of common names such as  kacangkayulaut (Malay), karanja (Hindi, Bengali, and Sanskrit) and pongam oil tree/malva nut (English). It is a medium-sized evergreen tree that fixes nitrogen and seeds yields up to 30–40% oil. Bark is smooth, glabrous and deciduous. Leaves are young, glossy, pinkish red, while mature leaves are lustrous and deep green. Flowers are fragrant with white to pinkish in colour11,12. It is widely grown throughout (Figure.1) Australia, Bangladesh, China, Egypt, Fiji, Indonesia, Japan, Kenya, Malaysia, Myanmar, Nepal, New Zealand, Northern Marianas, Pakistan, Saudi Arabia, South Africa, Seychelles, Singapore, Solomon Islands, Sri Lanka, Sudan, Taiwan, Thailand, Uganda, United States, Vietnam, Zambia and India mainly in (Bihar, Karnataka, Maharashtra and Haryana)13,14.

 

Figure 1. Geographical distribution of Pongamia pinnata15

 

Figure 2. Pongamia pinnata plant

 

Table No. 1 Plant Taxonomy (L.) 16

Kingdom

Plantae

Subkingdom

Tracheobionta

Super division

Spermatophyta

Division

Magnoliophyta

Class

Magnoliopsida

Subclass

Rosidae

Order

Fabales

Family

Fabaceae

Genus

Pongamia

Species

Pinnata

 

Plant is reported for its various traditional effects to treat variety of illnesses by many ethnic practitioners (Figure 3) (Table 2) such as in the management of cancer, piles, skin diseases, ulcers, and gonorrhoea. It also works well to clean teeth and gums17. According to reports, it has good anti-inflammatory18 anti-plasmodial19, anti-nociceptive20, anti-hyperglycaemic21, anti-lipidperoxidative22, anti-diarrheal23, anti-ulcer24, anti-hyperammonic25, anti-oxidant26 and antibacterial activities27. Pongamia pinnata contains numerous secondary metabolites/phytochemicals. Screening of phytochemicals from different parts of plant have shown the plant is rich in flavonoids, isoflavonoids, chalcones, alkaloids, flavanones28,29, hydroxyfuranoflavones, karanjin, lancheolatin B, kanjone, beta sitosterol glucosides30, desmethoxykanugin, pinnatin triterpenoids, rutin, vitexin, isoquercitrin, kaempferol and quercetin31,32

 

Figure 3. Pharmacological activity of Pongamia pinnata

 


Table No.2 Pharmacological activity of various parts of the plant

Sl. No

Plant Part used

Method

Activity

Reference

1.                     

Stem Bark

STZ Induced Diabetic Rat.

Cardioprotective activity of Pet Ether Extract of P. Pinnata Stem Bark in diabetic rats.

41

2.                     

Flower

α-amylase inhibitory method

Different isolated active constituents from the flowers of P. pinnata were screened for antidiabetic activity

42

3.                     

Leaf

Alloxan-induced diabetic model and OGTT.

Antidiabetic effect of P. pinnata leaves in alloxan-induced diabetic rats.

43

4.                     

Leaf

Alloxan β- cytotoxin induced diabetes model.

Antidiabetic potential of the polyherbal formulation which is a mixture of ethanolic extract of  Caesalpinia bonducella, Mucona puriens, Pongamia pinnata

44

5.                     

Leaf

Agar well diffusion method

Antifungal activity of Pongamia  pinnata L. extracts on saprolegnia isolated from diseased fishes.

45

6.                     

Leaf

 

Agar well diffusion method

Antibacterial properties of  leaf extracts of P. pinnata against some human pathogens,

47

7.                     

Leaf

 

Disc diffusion method

Antibacterial properties of leaves of P. pinnata, against enteric bacterial pathogens.

48

8.                     

Leaf

 

Agar well diffusion and Disc diffusion method

Antibacterial activity of  leaf  extract of  P. pinnata, C. long. and M. arvensis. against S. aureus bactria

 

51

9.                     

Leaf

In vitro anti-inflammatory activity by protein denaturation technique

Anti-inflammatory activities of methanolic extracts of P. pinnata and Diclofenac Sodium, using heat-induced protein denaturation technique.

60

10.                   

Leaf

 

Agar diffusion method

The antibacterial potential of Pongamia pinnata leaf extracts was tested against selected food-borne pathogens, highlighting its potential application as a natural antimicrobial agent in the pharmaceutical or food industry.

52

11.                   

Seed

Agar well diffusion and Disc diffusion method

Antibacterial activity of P. pinnata seed extracts using organic and aqueous solvent, against multidrug human pathogens.

50

12.                   

Seed

Inhibition of protein denaturation model & HRBC membrane stabilization model

Anti-arthritic activity of ethanolic extract of seeds of P. pinnata and methanolic extract of Punica granatum linn by in-vitro technique.

 

54

13.                   

Seed

Paw oedema method

Anti-inflammatory potential of different solvent fractionated seed extracts of P. pinnata, using chemically induced paw inflammation in rats.

61

14.                   

Seed

Nitric oxide and superoxide quenching properties, ABTS, iron chelating activities.

The seed extracts of Pongamia pinnata were assessed for their antioxidant and free radical scavenging properties, using a standard spectrophotometric protocol for estimation..

62

15.                   

Seed

Agar Well Diffusion Method

Antimicrobial efficacy of seed extracts of P. pinnata against P. aeruginosa, S. aureus, S. epidermidis, M. furfur, and C. albicans.

58

16.                   

Seed, Bark, Leaf, Root

Well diffusion method

Fungitoxic properties of P. pinnata against two human pathogenic fungi and two plant pathogenic fungal strains.

46

17.                   

Leaf and Seed

Cup diffusion method

Evaluation of antibacterial potential of P. pinnata against Xanthomonas axonopodis punicae, phytopathovar of Bacterial blight of Pomegranate.

49

18.                   

Leaf, Bark, Flower, and Root.

BSL and THP-1 Cell Line study/ Invitro Antimalarial activity.

Different extracts of P. pinnata were screened for In vitro antimalarial activity against P. falciparum 3D7 strain.

53

19.                   

Bark

Acetic acid-induced abdominal writhing & ELISA in carrageenan and cotton pellet granuloma test

Alcoholic extract of stem bark of P. pinnata was studied for its analgesic and anti-inflammatory activity in rats,  Serum TNF-alpha and IL-1beta were measured by ELISA.

59

20.                   

Bark

Agar Well Diffusion Method

The hydroalcoholic bark extract of Pongamia pinnata was evaluated for its antimicrobial potential against various pathogens, including Bacillus subtilis, Escherichia coli, and Aspergillus niger.

55

21.                   

Leaf, Stem, Bark, Flower.

Agar Well Diffusion Method

Different parts of P. pinnata were screened for its antimicrobial activity against bacterial pathogens.

56

22.                   

Leaf, Bark, Seed

Disc diffusion method

Various extracts of P. pinnata were examined for  antimicrobial potential against Gram + and – bacteria and fungal species.

57

23.                   

Leaf, Bark, Seed

DPPH radical scavenging activity

Different parts of P. pinnata were studied for its antioxidant properties and maximum extraction yield of antioxidant components from bark, leaves, seeds were estimated.

63

 


Pharmacognostic Study:

Phytochemically leaf powder of P. pinnata was reported to have alkaloids, flavonoids, steroids, triterpenes, cardiac glycosides and saponins33,34. Ethanolic extracts of  leaves have been studied for various phytocompounds and report disclosed the presence of Flavonoids, alkaloids, carbohydrates, proteins, terpenoids, steroids and glycosides35. Seed extract shows the presence of phenols, flavonoids, tannins, saponins, alkaloids, fats and fixed oils. The total flavonoids content of hydro alcoholic extract of plant was 1.398 mg/100mg36. Acetone and chloroform extracts of pinnata contains flavonoids, tannins, and cardiac glycosides in acetone extract and alkaloids and saponins were present in chloroform extract37 .Pharmacognostic studies were carried out to evaluate organoleptic, microscopic, physicochemical parameters of stem bark of Pongamia pinnata. Results revealed various microscopical characters like Phellogen, Parenchymatous cells, Phloem fibres, Wavy medullary rays and Physicochemical investigation of bark revealed total ash value 10.94%w/w, water soluble ash 1.96%w/w, acid insoluble ash 1.47%w/w and sulphated ash 15.8% w/w respectively.  The alcohol and water-soluble extractive value were 9.6 & 18.4%w/w.38. P. pinnata stalk was used for extracting cellulosic natural fibres which were characterised and through compositional analysis it revealed fibres have 54% cellulose, 12% hemi cellulose, 15% ligands and 11% ash. The tensile strength of fibre was 310 MPa which is equivalent to cotton and linen. The tensile strength of P. pinnata fibre reinforced polypropylene composite was 17.96 MPa which is equivalent to other natural fibre based composite39. Karanjin was extracted from seeds using Ultrasound assisted extraction technique which was the most efficient mode of extraction using methanol as solvent. Extraction temperature of 57.850C, extraction time of 25.45 minute and solvent to drug ratio of 86.4709 W/V was the optimum condition for extraction. The non thermal method of extraction, (UAE) is most efficient mode of extraction and polar solvents are most promising solvents for extraction of Karanjin40.

 

Biological activities:

Antidiabetic activity:

Petroleum ether extract of stem bark of plant was studied for its hypoglycaemic activity. Findings suggested that blood glucose level was reduced with improved electro cardiography, hemo-dynamic parameters and enhanced oxidative stress in STZ induced diabetic rats41. Three isomeric furano flavonoids from hexane extract of flowers of P. pinnata were studied for antidiabetic screening using in-vitro model which showed higher anti diabetic activity as that of standard Acarbose42. Ethanolic and aqueous extracts of leaves were compared with standard Glibenclamide in alloxan induced diabetic rats, the extracts revealed their potency and proved their anti-diabetic effects in rats and reduced mortality rate43. P. pinnata in combination with Caesalpinia bonducella, Mucona puriens were subjected to investigate the antihyperglycemic activity in alloxan induced diabetic rats and revealed better results due to restoration or regeneration of beta cells of pancreas44.

 

Antifungal activity:

P. pinnata extracts were used for evaluation of antifungal activity on Saprolegnia parasitica isolated from cultured and wild fishes. The extracts showed highest growth inhibition. It proved to be a potent antifungal remedy45. Extracts of different plant parts of (seeds, bark, leaves, roots) were subjected to investigate fungi toxic properties against two human pathogens- Epidermophyton floccosum and Candida albicans and 2 plant pathogens- Alternaria solani and Helminthosporiumturcicun. Amongst all extracts the seed extract showed higher antifungal activities followed by roots, barks while the leaves extract showed the least activity. E. Floccosum was more susceptible to all extracts followed by C. albicans, whereas H. turcicun was more resistant to all extracts followed by A. Solani46.

 

Antibacterial activity:

P. pinnata leaf ethanolic extract has probable antibacterial effect against some human pathogens- C. violaceum, C. frendii, S. aureus and M. luteus. The activity was measured by Agar well diffusion method.  Zone of inhibition was studied and highest zone of inhibition of ethanolic extract was observed against gram positive bacteria M. luteus (38mm) and smallest was observed against C. freundii (17.6mm)47. Various extracts of leaves (petroleum ether, chloroform, ethyl acetate, methanol) were screened by disc diffusion method against some enteric bacterial pathogens such as E. coli, S.aureus, E. aerogenes, P. aeruginosa, S. typhimurium, S. typhi, S. epidermidis and P. vulgaris. The methanolic extracts exhibits wide range of antibacterial activity on these bacterial pathogens than pet ether extracts, whereas the ethyl acetate extracts show slightly higher than chloroform extract48. The aqueous and other solvent extracts of  P. pinnata leaves and seeds were tested against Xanthomonas axonopodispv. punicae, phytopathovar of bacterial blight of Pomegranate using agar cup diffusion method. The extracts were prepared in 6 solvents namely; water, ethanol, methanol, diethyl ether, benzene and chloroform. Aqueous, ethanol, methanol, extracts of leaves and seeds showed significant activity against X. axonopodispunicae. Minimum inhibitory concentration of these extracts ranged between 400- 500µg/ml. The Methanol extract of leaves and aqueous extract of seeds shows maximum antibacterial activity against the pathogen49. The aqueous, chloroform, ethanol, methanol, petroleum ether extracts of plant were tested against multi drug human pathogens. The ethanolic extract showed highest anti- S. typhi activity and was effective against all bacterial strains. Methanol, chloroform, aqueous extracts showed moderate activity and petroleum ether showed minimum inhibitory activity50. Anti-bacterial activity of P. pinnata, Curcuma longa and Mentha arvensisa comparative studies were performed against Staphylococcus aureus. Aqueous extract of M. arvensis is more effective than methanolic and ethanolic extracts; ethanolic extract of P.pinnatais more effective than the aqueous and methanolic extract; ethanolic extract of Curcuma longa leaf extract is more effective than methanolic and aqueous extract51. The organic extracts of leaves were tested against some food born pathogenic bacteria. The organic extracts of chloroform, ethylacetate and methanol at concentration of 2500µg/ ml showed good effect against B. subtilis, S. aureus, L. monocytogenes, P. aeruginosa and S. typhimurium. The zones of inhibition were in range of 8.1 to 18mm and MIC value from 125 to 1000µg/ml. The chloroform, ethyl acetate and methanol extracts show greater activity as compared to streptomycin52.

 

Antimalarial activity:

To assess the in vitro anti-malarial efficacy against the Plasmodium falciparum 3D7 strain, natural extracts from methanol, chloroform, hexane, ethyl acetate, and aqueous extracts of dried leaves, bark, and roots of Pongamia pinnata were screened. The methanolic bark extract demonstrated significant in vitro anti-malarial activity, with an IC50 value of 11.67µg/ml.53

 

Antiarthritic activity:

Ethanolic extract of P. pinnata and methanolic extract of Punica granatum in comparison were examined for antiarthritic activity by in vitro techniques i.e., inhibition of protein denaturation and HRBC membrane stabilization, Diclofenac sodium was used as standard. Protein denaturation was inhibited and stabilization toward the HRBC membrane was observed by ethanolic extract of P.pinnata and Methanolic extract of Punica granatum. Study revealed that MEPG has more potent activity than EEPP54.

 

Antimicrobial activity:

The hydro alcoholic bark extract was subjected for antimicrobial activity organisms included for activity were B. subtilis, E. coli and A. niger. The MIC of extract against all organism was 100µg/ml which is consistent. The extract shows synergistic effect with antibiotics and reduces the MIC of respective antibiotics towards pathogenic bacteria55. In another study the bioactive compounds from leaves, seed, bark, flowers were extracted by soxhlet among all parts the seeds and leaves extract exhibited maximum zone of inhibition in most bacterial pathogens at a concentration of 400µg/ml56. Different polarity solvents like pet. ether and ethyl acetate extracts were examined against gram positive and negative bacteria using the disc diffusion method. The extracts of leaves, bark, seeds from pet ether and ethyl acetate extracts showed an inhibition zone on B. subtilis and S. aureus. Extracts from seeds of pet ether (72.00±0.57) and ethyl acetate (72.00±0.00) showed maximum inhibition zone on B. subtilis, while leaf extract of Pet ether (17.66±0.66) and ethyl acetate (21.16±0.16) showed similar activity against S. aureus, E. coli, C. Albicans57. Ethyl acetate seed extracts evaluated against P. aeruginosa, S. aureus, S. epidermidis, M. furfur and C. albicans by Agar well diffusion essay, resulted that S. epidermidis was the most sensible strain among all the tested pathogens. Ethyl acetate extract of seeds show the inhibition zone of 41.05±0.7mm58 .

 

Anti-inflammatory activity:

Alcoholic extract of stem bark of P. pinnata was evaluated for its analgesic and anti-inflammatory activity in rats. Serum TNF alpha and IL 1 beta were measured by Eliza the extract exhibited notable analgesic and anti-inflammatory activity with decreased serum TNF alpha and IL 1 beta in acute as well as chronic anti-inflammatory studies59. Methanolic extract of leaves was studied for in-vitroanti-inflammatory activity using heat induced protein denaturation technique where diclofenac sodium was used as reference standard. The concentration of leaf extract and diclofenac sodium was 50 to 250µg/ml. Diclofenac sodium and methanolic extract of leaves showed IC50 value up to 18.36 and 82.24µg/ml respectively60. Different solvent fractionated seed extracts were tested in chemically induced paw inflammation in rats. The activity was best seen against Bradykinin and PGE1 induced inflammation and minimal effect was seen against histamine and 5 HT induced inflammation. The polar constituents in seeds appear to have anti-inflammatory principles61.

 

Antioxidant activity:

The antioxidant properties of Pongamia pinnata seed oil were evaluated using various scavenging assays. Karanjin, pongapin, and yellow oil were isolated from the hexane extract. Four different assays were conducted: superoxide quenching, nitric oxide scavenging, iron chelation, and total antioxidant status, all measured via spectrophotometry. The active compounds exhibited varying degrees of superoxide, nitric oxide, and iron chelating activity, contributing to a strong overall antioxidant capacity. Superoxide scavenging activity was tested at different concentrations, with the highest activity observed in pongapin (37.97%), followed by Karanjin (34.47%) and yellow oil (6.47%). In nitric oxide scavenging, ascorbic acid, used as a standard, showed maximum inhibition (89.14%). Among the seed oil components, Karanjin had the highest inhibition (88.47%), followed by pongapin (62.31%) and yellow oil (2.4%). Superoxide scavenging was also evaluated across different concentrations, where pongapin had the highest activity (0.61%), exceeding that of Karanjin (0.25%) and yellow oil (0.75%). In iron chelation, pongapin showed the greatest inhibition (87.12%), followed by yellow oil (81.27%) and Karanjin (30.17%)62. Antioxidant properties of different parts (bark, leaves, seeds) of P. pinnata was studied. The obtained bark extract from aqueous methanol showed higher DPPH radicals scavenging activity with IC 50 value of 3.21 µg/ml followed by leaves and seed extract. Bark has an enormous opportunity for antioxidants application in medications63.

 

Neuro-protective activity:

Ethanolic extract of stem bark of P. Pinnata was studied for monosodium glutamate-induced neurotoxicity in rats. According to the study, ethanolic extract of stem bark has significant neuroprotective effects on albino rats64.

 

Antiviral activity:

Isolated chemical 1, bis (2-methylheptyl) phthalate, from the P. pinnata extract effectively suppressed the White Spot Syndrome Virus (WSSV). After being exposed to WSSV for 15 days, the Penaeus monodon group that was fed the1, bis(2-methylheptyl) phthalate and experimentally challenged with the virus exhibited 60% and 50% survival rates, respectively, at 100 and 150 µg/gm per day. The results of this study demonstrated that 1, bis(2-methylheptyl) phthalate is the antiviral WSSV chemical found in P. pinnata leaves65.

 

Analytical study:

HPTLC:

The leaf extract of Pongamia pinnata was analyzed using the HPTLC fingerprinting technique at a wavelength of 254nm, revealing various phytochemicals with Rf values ranging from 0.01 to 0.97. Among these, the highest concentration of phytochemicals was 32.66%. Several secondary metabolites, including alkaloids, carbohydrates, steroids, tannins, flavonoids, terpenoids, coumarins, phenols, and quinones, were identified in the extract.66 A sensitive, selective, and precise TLC method was developed and validated for the analysis of Karanjin. The separation was carried out using TLC with a mobile phase of ethanol and ethyl acetate in a 7:3 v/v ratio. The retention factor (Rf) was determined to be 0.69. The calibration curve showed linearity within the concentration range of 0.1 to 1.2 µg/spot. The developed method demonstrated linearity, precision, accuracy, and specificity67. Phytochemical screening and HPTLC analysis of methanolic extracts from seeds and callus were conducted using a mobile phase of toluene and ethyl acetate in a 9:1 ratio. The HPTLC results revealed a common band with an Rf value of 0.36 in seed oil, methanolic seed extract, and callus, indicating the presence of a novel compound in both the methanolic extracts of seeds and callus.68

 

HPLC:

A novel, stable HPLC method was developed for the estimation of Karanjin, utilizing an RP-C18 column with detection at 260nm using a PDA detector. The mobile phase consisted of methanol, acetonitrile (ACN), and water in a 70:15:15 v/v ratio. The developed method was precise, specific, and accurate69. A reverse-phase HPLC method was developed to analyze Karanjin in Pongamia pinnata leaves. The analysis was performed on a C18 column using a mobile phase consisting of a mixture of methanol, water, and acetic acid (85:13.5:1.5 v/v) at a flow rate of 1ml per minute, with UV detection at 300nm. The method was validated and found to be specific, accurate, precise, reliable, and reproducible. It showed good linear correlation coefficients, with detection and quantification limits of 4.35µg and 16.56 µg, respectively. This method can be used for quantitative analysis and quality control of leaves, with Karanjin serving as a marker compound.70

 

CONCLUSION:

A significant proportion of the population in developing countries, more than 80% as per the World Health Organization, receive their primary medical care through herbal remedies. The well-documented safety and effectiveness of natural compounds, particularly those sourced from plants, have sparked considerable interest in their utilization in traditional and ethnobotanical medicine. It is essential to adopt a conventional strategy in the exploration of novel substances to tackle a spectrum of diseases. Pongamia pinnata has been commonly used for treating a wide array of illnesses. Its therapeutic attributes can be found in every part of the plant, which are applied in the treatment of wounds, piles, ulcers, and skin conditions. Analysis of phytochemicals has indicated that the plant contains a variety of secondary metabolites. In traditional medicine, the plant is recognized for its anti-diabetic, anti-inflammatory, antifungal, antibacterial, anti-malarial, antimicrobial, antiviral, and antioxidant properties. The primary focus of this review was to provide an overview of the pharmacological uses of P. pinnata, the diverse chemical constituents within the plant, and the analytical methods used for standardization. The future perspective of this medicinal plant is to isolate desired phytocompounds of therapeutic interest and development of novel drug delivery thereof.

 

ACKNOWLEDGEMENT:

The authors thank Principal, KLE College of Pharmacy and Department of Pharmacognosy, KLE College of Pharmacy Belagavi, for all the support to complete this review.

 

CONFLICT OF INTEREST:

The authors declare that they have no conflict of interest.

 

REFERENCES:

1.      Patil SB, Jalalpure SS, Kunchanur MG. Validated HPTLC Method for Detection of Kaempferol in Moringa oleifera Leaf Extract and Investigation of its Antidiabetic Potential by In Vitro and In Silico Studies. Journal of Natural Remedies. 2024; 7: 1961-74. https://doi.org/10.18311/jnr/2024/36553

2.      Dukre TP, Wadekar GN, Pawar HB. Pharmacognostic and Phytochemical Evaluation of Herbal Plant: Alangium lamarkii (Alangiaceae). Research Journal of Pharmacognosy and Phytochemistry. 2022; 14(2): 65-8.

3.      Patil S, Khushwah P, Gudasi S, Patil M, Kunchanur M, Koli R. Simultaneous Determination of Gallic Acid, Berberine and Trigonelline in Polyherbal Churna by HPTLC Method. J Young Pharm. 2024; 16(2): 261-8. https://doi.org/10.5530/jyp.2024.16.34

4.      Chandewar AV, Kochar NI, Shrirao AV, Karpe ST. Phytochemical screening, chromatographic and quantitative study of phenols and flavonoids in leaves of Oroxylum indicum and Pongamia pinnata. Research Journal of Pharmacy and Technology. 2023; 16(6): 2604-8. DOI:10.52711/0974-360x.2023.00427

5.      Khajuria R, Kaur L, Kaushik A, Saredia G. Evaluation of antimicrobial and phytochemical properties of some Indigenous Indian plants. Research Journal of Pharmacognosy and Phytochemistry. 2014; 6(1): 5-8.

6.      Sundar RD, Settu S, Shankar S, Segaran G, Sathiavelu M. Potential medicinal plants to treat leprosy-a review. Research Journal of Pharmacy and Technology. 2018; 11(2): 813-21. DOI: 10.5958/0974-360X.2018.00153.1

7.      Rungsung W, Dutta S, Hazra J. Pharmacognostical Approach towards Authentication and Quality Evaluation of Medicinal Plants-A Compendious Description. Research Journal of Pharmacognosy and Phytochemistry. 2013; 5(2): 77-83.

8.      Jalalpure SS, Patil KS. Pharmacognostic and In-vitro Antioxidant Antimicrobial potentials of Jayanti   Veda (Tridax procumbens L.). International Journal of Ayurvedic Medicine. 2022; 13(3): 711-7. doi: org/10.47552/ijam.v13i3.2989.

9.      Soundalgekar S, Naik A, Hullatti K, Jalalpure S, Patil S, Gaonkar VP. HPTLC fingerprinting and anti-asthmatic activity of roots of two different sources of Bharangi. Indian Journal of Natural Products. 2021; 35(1): 25-31. doi:10.5530/ijnp.2021.1.6.

10.   Sumathi R, Pavni S, Sivakumar T. Antimicrobial evaluation of lipid extract of Pongamia pinnata leaves. Research Journal of Pharmacy and Technology. 2009; 2(4): 714-8.

11.   Al Muqarrabun LM, Ahmat N, Ruzaina SA, Ismail NH, Sahidin I. Medicinal uses, phytochemistry and pharmacology of Pongamia pinnata (L.) Pierre: A review. Journal of Ethnopharmacology. 2013; 150(2): 395-420.doi:10.1016/j.jep.2013.08.041.

12.   Chopade VV, Tankar AN, Pande VV, Tekade AR, Gowekar NM, Bhandari SR, Khandake SN. Pongamia pinnata: Phytochemical constituents, traditional uses and pharmacological properties: A review. International Journal of Green Pharmacy (IJGP). 2008; 2(2): 72-75. doi:org/10.22377/ijgp.v2i2.31.

13.   Degani E, Prasad MV, Paradkar A, Pena R, Soltangheisi A, Ullah I, Warr B, Tibbett M. A critical review of Pongamia pinnata multiple applications: from land remediation and carbon sequestration to socioeconomic benefits. Journal of Environmental Management. 2022; 324: 1-20. doi:org/10.1016/j.jenvman.2022.116297.

14.   Kesari V, Rangan L. Development of Pongamia pinnata as an alternative biofuel crop current status and scope of plantations in India. Journal of Crop Science and Biotechnology. 2010; 13: 127-37. doi:10.5555/20113009404

15.   Dalemans F, Fremout T, Gowda B, Van Meerbeek K, Muys B. Tempering expectations on a novel biofuel tree: Seed and oil yield assessment of pongamia (Millettia pinnata) shows low productivity and high variability. Industrial Crops and Products. 2022; 178: 114384. doi;org/10.1016/j.indcrop.2021.114384

16.   Battu GR, Devarakonda R, Chandra S. Pharmacognostic, Phytochemical and In vivo Hepatoprotective Activity on Pongamia pinnata Linn Bark. International Journal of Pharmacognosy and Chinese Medicine. 2019 Aug; 3(3): 1-10.  doi:10.23880/ipcm-16000172

17.   Pulipati S, Babu PS, Lakshmi DN, Navyasri N, Harshini Y, Vyshnavi J, Prasanth M. A phyto pharmacological review on a versatile medicinal plant: Pongamia pinnata (L.) pierre. Journal of Pharmacognosy and Phytochemistry. 2018; 7(4): 459-63.

18.   Smitha GN, Asif AK, Mukesh SS, Geetanjali SS. Anti-inflammatory activity of Pongamia pinnata stems bark in rats. Journal of Pharmacy Research. 2010; 3(4): 828-30.

19.   Singh N, Kaushik NK, Mohanakrishnan D, Tiwari SK, Sahal D. Antiplasmodial activity of medicinal plants from Chhotanagpur plateau, Jharkhand, India. Journal of Ethnopharmacology. 2015; 165:152-62.  doi: 10.1016/j.jep.2015.02.038.

20.   Srinivasan K, Muruganandan S, Lal J, Chandra S, Tandan SK, Raviprakash V, Kumar D. Antinociceptive and antipyretic activities of Pongamia pinnata leaves. Phytotherapy Research. 2003; 17(3): 259-64.doi: 10.1002/ptr.1126.

21.   Tamrakar AK, Yadav PP, Tiwari P, Maurya R, Srivastava AK. Identification of pongamol and karanjin as lead compounds with antihyperglycemic activity from Pongamia pinnata fruits. Journal of Ethnopharmacology. 2008; 118(3): 435-9. doi: 10.1016/j.jep.2008.05.008.

22.   Punitha R, Manoharan S. Antihyperglycemic and antilipidperoxidative effects of Pongamia pinnata (Linn.) Pierre flowers in alloxan induced diabetic rats. Journal of ethnopharmacology. 2006; 105(1-2): 39-46. doi: 10.1016/j.jep.2005.09.037.

23.   Brijesh S, Daswani PG, Tetali P, Rojatkar SR, Antia NH, Birdi TJ. Studies on Pongamia pinnata (L.) Pierre leaves: understanding the mechanism (s) of action in infectious diarrhea. Journal of Zhejiang University Science. B. 2006; 7: 665-74. doi: 10.1631/jzus.2006.B0665.

24.   Pandey A, Jakhetia V, Sharma S. Antiulcer activity of Pongamia pinnata in rats. Journal of Drug Delivery and Therapeutics. 2013; 3(3):85-89.doi:org/10.22270/jddt.v3i3.525

25.   Mohamed Essa M, Subramanian P. Pongamia pinnata modulates the oxidant–antioxidant imbalance in ammonium chloride‐induced hyperammonemic rats. Fundamental and Clinical Pharmacology. 2006; 20(3):299-303.doi: 10.1111/j.1472-8206.2006.00410.x.

26.   Dwivedi D, Dwivedi M, Malviya S, Singh V. Evaluation of wound healing, anti-microbial and antioxidant potential of Pongamia pinnata in wistar rats. Journal of traditional and complementary medicine. 2017; 7(1): 79-85. doi: 10.1016/j.jtcme.2015.12.002.

27.   Anuradha R, Krishnamoorthy P. Screening of phytochemicals and identification of chemical constituents of Pongamia pinnata by GC-MS. Inter J Chem Tech Res. 2012; 4: 16-20.

28.   Al Muqarrabun LM, Ahmat N, Ruzaina SA, Ismail NH, Sahidin I. Medicinal uses, phytochemistry and pharmacology of Pongamia pinnata (L.) Pierre: A review. Journal of ethnopharmacology. 2013; 150(2): 395-420. doi: 10.1016/j.jep.2013.08.041.

29.   Li J, Jiang Z, Li X, Hou Y, Liu F, Li N, Liu X, Yang L, Chen G. Natural therapeutic agents for neurodegenerative diseases from a traditional herbal medicine Pongamia pinnata (L.) Pierre. Bioorganic & Medicinal Chemistry Letters. 2015; 25(1): 53-8. doi: 10.1016/j.bmcl.2014.11.015.

30.   Khare CP. Encyclopedia of indian medicinal plants: rational western therapy, ayurvedic and other traditional usage, botany. Springer; 2004. doi:org/10.1007/978-3-642-18659-2

31.   Marzouk MS, Ibrahim MT, El-Gindi OR, Bakr MS. Isoflavonoid glycosides and rotenoids from Pongamia pinnata leaves. Zeitschrift für Naturforschung C. 2008; 63(1-2): 1-7. doi: 10.1515/znc-2008-1-201.

32.   Ahmad G, Yadav PP, Maurya R. Furanoflavonoid glycosides from Pongamia pinnata fruits. Phytochemistry. 2004; 65(7): 921-4.doi: 10.1016/j.phytochem.2004.01.020.

33.   Disha M, Sumitra C. Phytochemical and pharmacognostic evaluation of leaves of Pongamia pinnata L.(Fabaceae). Pharmacognosy Communications. 2014; 4(2): 3-7. doi: 10.5530/pc.2014.2.2

34.   Chandewar AV, Kochar NI, Shrirao AV, Karpe ST. Phytochemical screening, chromatographic and quantitative study of phenols and flavonoids in leaves of Oroxylum indicum and Pongamia pinnata. Research Journal of Pharmacy and Technology. 2023; 16(6): 2604-8. doi:10.52711/0974-360X.2023.00427 

35.   Yadav RD, Jain SK, Alok S, Kailasiya D, Kanaujia VK, Kaur S. A study on Phytochemical investigation of Pongamia pinnata Linn. leaves. International Journal of Pharmaceutical Sciences and Research. 2011; 2(8): 2073-79. doi:org/10.13040/IJPSR.0975-8232.

36.   Mishra R, Pounikar Y, Gangwar M. Extraction, Phytochemical screening and quantitative determination of phenols and flavonoids in extract of Kalanchoe pinnata and Pongamia pinnata. Journal of Drug Delivery and Therapeutics. 2019; 9(4): 192-6. doi:org/10.22270/jddt.v9i4.3024

37.   Sharmila D, Banu S. Phytochemical Analysis of Various Extracts of Pongamia glabra. Int J Pharm Sci Rev Res. 2015; 31(1):32-4.

38.   Kumar D, Kumar A, Prakash O. Pharmacognostic evaluation of stem bark of Pongamia pinnata (L.) Pierre. Asian Pacific Journal of Tropical Biomedicine. 2012; 2(2): S543-6. doi:10.1016/S2221-1691(12)60270-6

39.   Mohankumara PB, Thakare SP, Guna V, Arpitha GR. Millettia pinnata: a study on the extraction of fibers and reinforced composites. Bioresources and Bioprocessing. 2020; 7: 1-6. doi: 10.1186/s40643-019-0292-2

40.   Ansari SA, Abidin L, Gupta T, Mujeeb M, Ahmad A, Ahmad V, Mir SR. Statistical approach towards optimization of extraction process of karanjin from Pongamia pinnata seeds. Pharmacognosy Magazine. 2019; 15(Suppl 3): 419-25. doi:10.4103/pm.pm_609_18

41.   Badole SL, Chaudhari SM, Jangam GB, Kandhare AD, Bodhankar SL. Cardioprotective activity of Pongamia pinnata in streptozotocin-nicotinamide induced diabetic rats. BioMed research international. 2015; 2015:1-8. doi: 10.1155/2015/403291.

42.   Saghir F, Hussain K, Tahir MN, Raza SA, Shehzadi N, Iftikhar S, Shaukat A, Naheed S, Siddique S. antidiabetic screening, activity-guided isolation and molecular docking studies of flower extracts of Pongamia pinnata (L.) pierre. Journal of Medicinal plants and By-product. 2021; 10(1): 85-92. doi: 10.22092/jmpb.2020.343368.1222.

43.   Sikarwar MS, Patil MB. Antidiabetic activity of Pongamia pinnata leaf extracts in alloxan-induced diabetic rats. International Journal of Ayurveda Research. 2010; 1(4): 199. doi: 10.4103/0974-7788.76780.

44.   Selvam P. Evaluation of antidiabetic activity of a polyherbal formulation in alloxan induced diabetic rats. Int. J. Pham. Sci. Res. 2010; 1(9): 82-7. doi.org/10.13040/IJPSR.0975-8232.

45.   Gorgile VT. Evaluation of antifungal activity of Pongamia pinnata L on Saprolegnia parasitica isolated from cultured and wild Fishes. Journal of Survey in Fisheries Sciences. 2023; 10(2S): 4063-7.

46.   More DR, Baig MM. Fungitoxic properties of Pongamia pinnata (L) Pierre extracts against pathogenic fungi. International Journal of Advanced Biotechnology and Research. 2013; 4(4): 560-7.

47.   Asaiya A, Raj D, Prajapati C. Antibacterial Effect of Pongamia pinnata Leaf Extract Against Some Human Pathogenic Bacteria. J Plant PatholMicrobiol. 2021; 12: 565. doi: 10.35248/2157-7471.21.12.565

48.   Arote SR, Dahikar SB, Yeole PG. Phytochemical screening and antibacterial properties of leaves of Pongamia pinnata Linn.(Fabaceae) from India. African Journal of Biotechnology. 2009; 8(22): 6393. doi: 10.5897/AJB2009.000-9487

49.   Gargade VA, Kadam DG. In vitro evaluation of antibacterial potential of Pongamia pinnata L. against Xanthomonas axonopodispunicae, phytopathovar of Bacterial blight of Pomegranate (Punica granatum). International Journal of Current Microbiology and Applied Sciences. 2015; 4(5): 824-33.

50.   Deshmukh MM, Kashid NG. Phytochemical Investigation And Antibacterial Activiy Of Pongamia pinnata (L). Against Some Multidrug Human Pathogens. International Journal of Research and Analytical Reviews. 2018: (5): 743-752

51.   Panigrahi S, Mahaprata S. Evaluation of antibacterial activity of. Pongamia pinnata. 2016:205-12.

52.   Bajpai VK, Rahman A, Shukla S, Mehta A, Shukla S, Arafat SY, Rahman MM, Ferdousi Z. Antibacterial activity of leaf extracts of Pongamia pinnata from India. Pharmaceutical biology. 2009; 47(12): 1162-7. doi:10.3109/13880200903019218

53.   Satish PV, Sunita K. Antimalarial efficacy of Pongamia pinnata (L) Pierre against Plasmodium falciparum (3D7 strain) and Plasmodium berghei (ANKA)(Retraction of Vol 17, Pg 458, 2017). doi: 10.1186/s12906-017-1958-y.

54.   Gautam KR, Sharma S, Sharma KO. Comparative evaluation of anti-arthritic activity of Pongamia pinnata (Linn.) Pierre and Punica granatum Linn.: An in vitro study. Int J Pharm Pharm Sci. 2013; 5(4): 721-4.

55.   Niharika P, Radhika G, Sri AK, Fathima S, Elisha Y. Antimicrobial activity of hydro-alcoholic bark extract of Pongamia pinnata. IJPSR. 2021; 12: 1149-54. doi:10.13040/IJPSR.0975-8232.12(2).1149-54

56.   Sharma S, Meher S, Tiwari SP, Bhadran S. Antimicrobial Activity and Phytochemical Analysis of Leaves, Seeds, Bark, Flowers of Pongamia pinnata (Linn. Pierre) Against Human Pathogens. Systematic Reviews in Pharmacy: 2021: (12): 234-240.

57.   Ujwal P, Kumar MP, Naika HR, Hosetti B. Antimicrobial activity of different extracts of Pongamia pinnata. Medicinal and aromatic plant science and Biotechnology. 2007; 1(2): 285-7.

58.   Rajput M, Bithel N, Vijayakumar S. Antimicrobial, antibiofilm, antioxidant, anticancer, and phytochemical composition of the seed extract of Pongamia pinnata. Archives of Microbiology. 2021; 203(7): 4005-24. doi: 10.1007/s00203-021-02365-9.

59.   Badole SL, Zanwar AA, Ghule AE, Ghosh P, Bodhankar SL. Analgesic and anti-inflammatory activity of alcoholic extract of stem bark of Pongamia pinnata (L.) Pierre. Biomedicine & Aging Pathology. 2012; 2(1):19-23.doi: 10.1016/j.biomag.2011.11.001

60.   Bairagi J, Katare V, Chourey B, Delouri A, Nema S. Evaluation of In-Vitro Anti-Inflammatory Activity of Leaves of Pongamia pinnata. Asian Journal of Dental and Health Sciences. 2023; 3(1): 8-10. doi:org/10.22270/ajdhs.v3i1.35

61.   Singh RK, Pandey BL. Anti-inflammatory activity of seed extracts of Ponamia pinnata in rat. Indian Journal of Physiology and Pharmacology. 1996; 40:355-8.

62.   Mitra AG, Mandal S, Das P, Dasgupta S, Mukhopadhyay S, Mukhopadhyay A, Banerjee J, Kar M. Antioxidant and free radical scavenging properties of seed components of Pongamia pinnata-a comparative study. Organic & Medicinal Chemistry International Journal. 2018; 7(5): 132-6. doi: 10.19080/OMCIJ.2018.07.555723.

63.   Sajid ZI, Anwar F, Shabir G, Rasul G, Alkharfy KM, Gilani AH. Antioxidant, antimicrobial properties and phenolics of different solvent extracts from bark, leaves and seeds of Pongamia pinnata (L.) Pierre. Molecules. 2012; 17(4): 3917-32.  doi: 10.3390/molecules17043917.

64.   Swamy AV, Patel NL, Gadad PC, Koti BC, Patel UM, Thippeswamy AH, Manjula DV. Neuroprotective activity of Pongamia pinnata in monosodium glutamate-induced neurotoxicity in rats. Indian Journal of Pharmaceutical Sciences. 2013; 75(6): 657.

65.   P. Rameshthangam, P. Ramasamy. Antiviral activity of bis(2- methylheptyl) phthalate isolated from Pongamia pinnata leaves against White Spot Syndrome Virus of Penaeus monodon Fabricius. Virus Research. 2007; 126: 38–44. doi: 10.1016/j.virusres.2007.01.014.

66.   BG Rajbhoj, Kumar S. Ethno-medicinal uses and HPTLC profiling of Tamarindus indica and Pongamia pinnata. Medico-Biowealthof India. 2015; 2 (6); ISBN: 978-81-952750-9-0. doi: 10.5281/zenodo.6828198.

67.   Sweety L, Patra KC, Dheeraj A, Rana AC, Debapriya G, Lanjhiyana SK. Development and validation of a HPTLC method for determination of Karanjin in Pongamia pinnata: a novel Indian medicinal plant. Der Pharmacia Sinica. 2012; 3(1):144-7. doi:10.5555/20123068668

68.   Shirsat R, Kengar A, Rai A. HPTLC profile and screening of antimicrobial activity of Pongamia pinnata pierre. Journal of Pharmaceutical Research International. 2021; 33 (30A): 205-15.doi:org/10.9734/jpri/2021/v33i30A31632

69.   Damle M, Choudhari S. Validated stability indicating method for Karanjin using HPTLC and HPLC. Journal of Pharmacognosy and Phytochemistry. 2018; 7(2): 2808-15.

70.   Katekhaye S, Kale MS, Laddha KS. Development and validation of an HPLC method for karanjin in Pongamia pinnata Linn. leaves. Indian Journal of Pharmaceutical Sciences. 2012; 74(1): 72. doi: 10.4103/0250-474X.102547.

 

 

 

Received on 05.08.2024      Revised on 18.01.2025

Accepted on 23.03.2025      Published on 02.08.2025

Available online from August 08, 2025

Research J. Pharmacy and Technology. 2025;18(8):3953-3960.

DOI: 10.52711/0974-360X.2025.00568

© RJPT All right reserved

 

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Creative Commons License.